Deal Details: Ireland’s biggest pharmaceutical wholesaler and distributor Uniphar acquires EPS Group and Irish-based M3 Medical.
The total potential cost of the two acquisitions is €40m over four years, with the deferred consideration linked to the earnings performance of the businesses over the four year period.
Both EPS Group and M3 Medical deliver sales, marketing and distribution services to medical device manufacturers in the areas of interventional cardiology and vascular medicine.
The EPS Group comprises EPS Vascular AB and EP Endovascular AB, both registered in Sweden, and EPS Vascular OY registered in Finland, delivering these services services across Sweden, Denmark, Norway, Finland, Iceland and the Baltics.
On a proforma basis for the full year ending 31 December 2019 the acquisitions in aggregate are expected to deliver revenues of c. €22m.
The acquisitions were financed out of the proceeds of the placing completed alongside the listing of the Group’s shares on 17 July 2019.